Methods of reducing side effects of anti-CD30 antibody drug conjugate therapy

• 收藏
• 分享

专利权人:

Inc.;Seattle Genetics

发明人:

MANLEY, Thomas,JOSEPHSON, Neil

申请号：

AU2018359546

公开号：

AU2018359546A1

申请日:

2018.11.01

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present disclosure, relates, in general to methods for improving adverse events in subjects having a mature T cell lymphoma and who are receiving treatment with an anti-CD30 antibody drug conjugate in combination with accompanying chemotherapy. Adverse events include peripheral neuropathy and neutropenia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/